Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Net Income (2016 - 2025)

Historic Net Income for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to -$2.9 million.

  • Palisade Bio's Net Income rose 1867.19% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.5 million, marking a year-over-year increase of 2168.81%. This contributed to the annual value of -$14.9 million for FY2024, which is 1364.92% down from last year.
  • According to the latest figures from Q3 2025, Palisade Bio's Net Income is -$2.9 million, which was up 1867.19% from -$2.8 million recorded in Q2 2025.
  • In the past 5 years, Palisade Bio's Net Income registered a high of -$2.3 million during Q1 2025, and its lowest value of -$33.5 million during Q2 2021.
  • Moreover, its 5-year median value for Net Income was -$3.6 million (2023), whereas its average is -$5.1 million.
  • As far as peak fluctuations go, Palisade Bio's Net Income plummeted by 171888.15% in 2021, and later surged by 8932.65% in 2022.
  • Quarter analysis of 5 years shows Palisade Bio's Net Income stood at -$3.0 million in 2021, then fell by 26.59% to -$3.9 million in 2022, then grew by 18.0% to -$3.2 million in 2023, then dropped by 7.19% to -$3.4 million in 2024, then rose by 13.53% to -$2.9 million in 2025.
  • Its Net Income stands at -$2.9 million for Q3 2025, versus -$2.8 million for Q2 2025 and -$2.3 million for Q1 2025.